Arvinas (ARVN) Accumulated Expenses (2017 - 2022)

Arvinas (ARVN) recorded quarterly Accumulated Expenses of $30.2 million in Q1 2022, up 30.74% quarter-over-quarter from $23.1 million in Q4 2021, and up 277.44% on a YoY basis from $8.0 million in Q1 2021.

Arvinas (ARVN) Accumulated Expenses (2017 - 2022) Analysis & Trends

Arvinas' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $30.2 million for Q1 2022.

  • In Q1 2022, Accumulated Expenses rose 277.44% year-over-year to $30.2 million; the TTM figure through Mar 2022 stood at $30.2 million (up 277.44% YoY), while the FY2021 annual figure was $23.1 million, up 22.22% from the prior year.
  • Accumulated Expenses was $30.2 million for Q1 2022 at Arvinas, up from $23.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $30.2 million in Q1 2022 to a low of $1.8 million in Q3 2018.
  • Historically, Accumulated Expenses has averaged $8.7 million across 5 years, with a median of $4.3 million in 2020.
  • The sharpest annual moves came in 2020 and 2021: Accumulated Expenses plunged 33.05% in 2020, then surged 305.43% in 2021.
  • A 5-year view of Accumulated Expenses shows it stood at $4.0 million in 2018, then surged by 45.22% to $5.8 million in 2019, then surged by 225.26% to $18.9 million in 2020, then grew by 22.22% to $23.1 million in 2021, then jumped by 30.74% to $30.2 million in 2022.
  • The last three Accumulated Expenses figures came in at $30.2 million (Q1 2022), $23.1 million (Q4 2021), and $13.8 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 30.20 Mn
Dec 31, 2021 23.10 Mn
Sep 30, 2021 13.77 Mn
Jun 30, 2021 4.70 Mn
Mar 31, 2021 8.00 Mn
Dec 31, 2020 18.90 Mn
Sep 30, 2020 4.34 Mn
Jun 30, 2020 2.98 Mn
Mar 31, 2020 1.97 Mn
Dec 31, 2019 5.81 Mn
Sep 30, 2019 3.68 Mn
Jun 30, 2019 4.00 Mn
Mar 31, 2019 2.95 Mn
Dec 31, 2018 4.00 Mn
Sep 30, 2018 1.78 Mn
Dec 31, 2017 3.55 Mn